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 ABSTRACT 
 MicroRNA (miRNA) are small single-stranded 
noncoding RNA with important roles in regulating 
innate immunity in nonruminants via transcriptional 
and posttranscriptional mechanisms. Mastitis causes 
significant losses in the dairy industry and a wealth of 
large-scale mRNA expression data from mammary tis-
sue have provided fundamental insights into the tissue 
adaptations to pathogens. We studied the expression 
of 14 miRNA (miR-10a, -15b, -16a, -17, -21, -31, -145, 
-146a, -146b, -155, -181a, -205, -221, and -223) asso-
ciated with regulation of innate immunity and mam-
mary epithelial cell function in tissue challenged with 
Streptococcus uberis. Those data, along with microarray 
expression of 2,102 differentially expressed genes, were 
used for bioinformatics analysis to uncover putative 
target genes and the most affected biological pathways 
and functions. Three miRNA (181a, 16, and 31) were 
downregulated approximately 3- to 5-fold and miR-223 
was upregulated approximately 2.5-fold in infected ver-
sus healthy tissue. Among differentially expressed genes 
due to infection, bioinformatics analysis revealed that 
the studied miRNA share in the regulation of a large 
number of metabolic (SCD, CD36, GPAM, and FASN), 
immune/oxidative stress (TNF, IL6, IL10, SOD2, LYZ, 
and TLR4), and cellular proliferation/differentiation 
(FOS and CASP4) target genes. This level of complex 
regulation was underscored by the coordinate effect 
revealed by bioinformatics on various cellular pathways 
within the Kyoto Encyclopedia of Genes and Genomes 
database. Most pathways associated with “cellular pro-
cesses,” “organismal systems,” and “diseases” were acti-
vated by putative target genes of miR-31and miR-16a, 
with an overlapping activation of “immune system” 
and “signal transduction.” A pronounced effect and 
activation of miR-31 target genes was observed within 
“folding, sorting, and degradation,” “cell growth and 
death,” and “cell communication” pathways, whereas 
a marked inhibition of “lipid metabolism” occurred. 
Putative targets of miR-181a had a strong effect on 
FcγR-mediated phagocytosis, toll-like receptor signal-
ing, and antigen processing and presentation, which 
were activated during intramammary infections. The 
targets of both miR-31 and miR-223 had an inhibitory 
effect on “lipid metabolism.” Overall, the combined 
analyses indicated that changes in mammary tissue 
immune, metabolic, and cell growth-related signaling 
pathways during infection might have been mediated in 
part through effects of miRNA on gene transcription. 
Differential expression of miRNA supports the view 
from nonruminant cells/tissues that certain miRNA 
might be essential for the tissue’s adaptive response to 
infection. 
 Key words:   microRNA ,  bovine ,  mammary epithelial 
cell 
 INTRODUCTION 
 Mastitis is a persistent, inflammatory response of 
mammary tissue attributed to intramammary invasion 
of a mastitis-causing pathogen such as Streptococcus 
uberis (Rinaldi et al., 2010). This potentially fatal in-
fectious challenge is the most common disease in dairy 
cattle in the United States (Bar et al., 2008; Harmon, 
1994). To effectively control mastitis pathogens, it is 
important to understand the mechanism controlling the 
immune response at the molecular level (Rinaldi et al., 
2010). 
 Recent reviews of the literature over the last decade 
have examined the mammary transcriptome in response 
to mastitis infection with different pathogens (Rinaldi et 
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al., 2010) and bioinformatics approaches for data min-
ing in a more holistic fashion (Loor et al., 2011). From 
that standpoint, it is well established in nonruminants 
that several microRNA (miRNA) play important 
functional roles across a wide spectrum of physiological 
and pathological processes (Tili et al., 2008; Kim et al., 
2009). These molecules are single-stranded noncoding 
RNA of 19 to 23 nucleotides that regulate the gene ex-
pression mainly at the posttranscriptional level. They 
may inhibit translation or destabilize the target RNA. 
Exploring the adaptations of mammary cell miRNA 
during mastitis would provide an additional level of 
understanding that could help explain the response of 
mammary epithelial cells to infection.
The recently identified miR-146, -181a, -151, -31, 
-223, -145, and -155 are known to regulate various 
biological pathways including immunity (Johnnidis 
et al., 2008), development and function of immune 
components (Johnnidis et al., 2008), and response to 
microbial infection (Taganov et al., 2006). For instance, 
the expression of miR-146 and miR-155 in B and T 
lymphocytes is induced in response to microbial infec-
tion (Eis et al., 2005; Taganov et al., 2006; Tam and 
Dahlberg, 2006). By inhibiting the expression of the im-
mune-related genes SPI1 (Vigorito et al. 2007), SOCS1 
(Lu et al., 2009), and SHIP1 (O’Connell et al., 2009), 
miR-155 plays important biological roles in different 
physiological conditions (e.g., its target, SHIP1, plays a 
role in activating AKT-dependent cellular events in rat 
mammary epithelial cells; Su et al., 2007). In addition, 
miR-16a regulates immunity by inhibiting the produc-
tion of inflammatory mediators through degradation, 
thus helping to reduce their level after inflammation in 
most nonruminant cell types (Jing et al., 2005). All of 
the above evidence suggests that certain miRNA might 
be particularly important in the modulation of immune 
response in mammary cells.
Each miRNA targets many genes; thus, the regula-
tory networks regulated by these molecules are likely to 
be substantial (Lewis et al., 2003) and may affect the 
cell’s response to bacterial infection (i.e., apoptosis in-
duction, adhesion and killing of invading bacteria, and 
cell tropism to bacteria in mammary epithelial cells; 
Wesson et al., 2000; Hensen et al., 2000). The general 
hypothesis of the present study was that expression of 
immune-related miRNA is altered by intramammary 
Strep. uberis infection, just as we observed for the tran-
scriptome (Moyes et al., 2009a). Specific objectives were 
to determine differential expression of selected miRNA, 
link the selected miRNA with their target genes in the 
microarray data set, and use bioinformatics to uncover 
the most affected pathways and functions within the 
data.
MATERIALS AND METHODS
miRNA Extraction, PCR, and Design  
and Evaluation of Primers
Details of the management of cows, experimental 
design, and tissue biopsy have been published in detail 
(Moyes et al., 2009a,b). Briefly, 10 multiparous cows 
past peak lactation (>60 d postpartum) with compos-
ite milk SCC <200,000 cells/mL were used. Biopsies 
of mammary tissue from both rear quarters of all cows 
(i.e., infected and noninfected quarters) were obtained 
20 h postchallenge. Tissue used in this study was the 
same as those used for transcriptomics (Moyes et al., 
2009a). Total RNA was extracted from mammary tissue 
using the mirVana miRNA isolation kit (AM1561; Life 
Technologies Corp., Carlsbad, CA). One hundred milli-
grams of mammary tissue was homogenized in 10 vol of 
mirVana Lysis/Binding Solution using a Tissue-Tearor 
(BioSpec Products Inc., Bartlesville, OK) homogenizer 
at maximum speed. Then one-tenth volume of miRNA 
homogenate additive was added, mixed thoroughly by 
vortexing for 30 s, and incubated on ice for 10 min. 
An equal volume of acid-phenol:chloroform (Life Tech-
nologies Corp.) was then added to each aliquot. The 
resulting solution was mixed by vortexing for 1 min and 
centrifuged for 5 min at 10,000 × g at room tempera-
ture (~23°C). The aqueous phase was carefully removed 
and then mixed thoroughly with 1.25 volumes of 100% 
ethanol and passed through a mirVana Filter Cartridge 
in sequential 700-μL aliquots. The filter cartridge was 
washed according to the manufacturer’s protocol and 
RNA was eluted in nuclease-free water at 95°C. Purity 
of RNA was assessed via a ratio of 260/280 using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies Inc., Rockland, DE).
Details on PCR and design and evaluation of primers 
are reported in the Supplementary File (available on-
line at http://www.journalofdairyscience.org/). Briefly, 
mammary tissue samples (Moyes et al., 2009a) were 
used for extraction of total RNA and enrichment of 
miRNA using a miRNA isolation kit. Quantitative PCR 
was performed using the NCode miRNA First-Strand 
Synthesis and quantitative real-time PCR (qRT-PCR) 
kits (MIRC10; Life Technologies Corp.), according to 
the manufacturer’s protocol. The reactions were per-
formed in an ABI Prism 7900 HT Sequence Detection 
Systems (SDS) instrument (Applied Biosystems Inc., 
Foster City, CA), and the data calculated with the 
7900 HT Sequence Detection Systems Software (version 
2.2.1; Applied Biosystems Inc.). The quantitative PCR 
performance data and sequence and primer information 
of U6 and small nucleolar RNA (snoRNA) are provided 
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in the Supplemental File (available online at http://
www.journalofdairyscience.org/).
Bioinformatics Analysis 
Identification of putative target genes among differ-
entially expressed genes [DEG; a total of 2,102 with 
unique Bos taurus gene identifications (ID)] due to 
Strep. uberis infection (Moyes et al., 2009a) for all of 
the miRNA studied was performed using the web-based 
software package Ingenuity Pathway Analysis (IPA; 
Ingenuity Systems Inc., Redwood City, CA). Each miR-
NA studied was assigned its corresponding B. taurus 
gene and miRBase ID before analysis against the bo-
vine 3c untranslated region (3c UTR) in the list of DEG. 
The IPA tool has a miRNA target filter function that 
relies on experimentally validated interactions from the 
TarBase database (Vergoulis et al., 2012), miRecords 
(http://mirecords.biolead.org/), TargetScan (http://
www.targetscan.org/), and manually curated miRNA-
related findings within the IPA knowledgebase. The lat-
ter pertains exclusively to information in the published 
scientific literature, whereas the first 3 methods rely on 
text mining-assisted curation (TarBase) or algorithms 
(TargetScan and miRecords) that find mRNA targets 
by searching for the presence of conserved 8mer (≥0.8 
conserved branch length) and 7mer sites that match 
the seed region of each miRNA. The total number of 
upregulated and downregulated target DEG is shown 
in Supplementary Table 3 (available online at http://
www.journalofdairyscience.org/). The complete list is 
found in Supplementary Table 4 and a partial list is 
shown in Figure 1.
Bioinformatics analysis to identify affected pathways, 
biological processes, and molecular functions within 
the DEG and the respective miRNA was performed 
using a novel approach we developed (dynamic impact 
approach, DIA) and have described previously (Bi-
onaz et al., 2012). Briefly, the entire microarray data 
set with associated statistical P-values were imported 
into IPA, The Database for Annotation, Visualization 
and Integrated Discovery (DAVID version 6.7; http://
david.abcc.ncifcrf.gov/) and Kyoto Encyclopedia of 
Genes and Genomes (KEGG) software (http://www.
genome.jp/kegg/). Entrez gene ID were used to identify 
individual sequences. The “Impact” refers to the abso-
lute perturbation in a biological process (i.e., overall 
dynamics within a term/pathway). It gives the magni-
tude of changes that occur (due to treatment) within 
a pathway/function in either direction weighted by the 
percent DEG that hit the term/pathway. The “Flux” 
refers to the overall direction in which a term/pathway 
is impacted after treatment (Bionaz et al., 2012; i.e., 
“activation” or “inhibition”). The length of the bars 
depicts the degree of the impact, and the intensity of 
the color (e.g., from dark green denoting highly down-
regulated to dark red denoting highly upregulated) was 
used to highlight the degree of activation or inhibition 
of pathways and terms. The entire KEGG and DAVID 
analysis can be found in Supplementary Tables 5 to 12 
(available online at http://www.journalofdairyscience.
org/).
RESULTS AND DISCUSSION
Details on local and systemic responses to IMI chal-
lenge with Strep. uberis are described elsewhere (Moyes 
et al., 2009b). All cows developed signs of mastitis. A 
complete list of the target genes of all selected miRNA 
among the 2,102 DEG found in the microarray is pro-
vided in Supplementary Table 4 (available online at 
http://www.journalofdairyscience.org/). Inhibition and 
activation of many physiologically relevant pathways 
was revealed using the DIA. The complete bioinformat-
ics analysis using KEGG on target genes of each miRNA 
is provided in Supplementary Tables 5 to 11 (available 
online at http://www.journalofdairyscience.org/), and 
the top 25 categories from the DAVID analysis for each 
miRNA studied can be found in Supplementary Table 
12. Among affected miRNA (Table 1; P ≤ 0.07), only 
miR-223 was upregulated, whereas miR-16a, -31, and 
-181a were downregulated in infected versus healthy 
mammary tissue. From the current bioinformatics 
analysis it was evident that immune- and cell survival-
related pathways were the most impacted; thus, they 
are the focus of the discussion.
miR-16a
The expression of miR-16a was lower (P < 0.05) in 
mammary tissue challenged with Strep. uberis (Table 
1). Relative to other miRNA studied, the target genes 
of miR-16a that were affected by IMI resulted in a clear 
impact and overall induction of “lipid metabolism,” “sig-
nal transduction,” and “immune system” (Figure 1). In 
particular, “TGF-beta signaling” was clearly activated 
by the lower expression of miR-16 and alterations in its 
target genes. The miR-16a is expressed at high levels 
in most nonruminant cells and tissues studied to date 
(Landgraf et al., 2007). A key function of miR-16a is to 
prevent cell cycle progression (Linsley et al., 2007) and 
maintain the level of inflammatory mediators in cells 
to regulate immunity after an infection (Jing et al., 
2005). Expression of miR-15b and IL6 were markedly 
upregulated in macrophages in response to a proinflam-
matory challenge (Dave and Khalili, 2010). The miR-
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Figure 1. Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/) categories uncovered by the dynamic impact 
approach (DIA) analysis using differentially expressed genes (DEG) that are putative targets of miR-31, -145, -181a, -223, and -15b/16a. Shown 
are the overall impact (left column) and flux (right shaded column) of the pathways for microRNA (miRNA). For interpretation of flux, gray 
horizontal bars (increasing toward the left) denote inhibition and black horizontal bars (increasing toward the right) denote activation. The 
length of the bar in the left column denotes the extent of the impact. Color version available in the online PDF.
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16a degrades tumor necrosis factor (TNF), IL8, and 
IL6 by acting on their 3c UTR after infection (Jing et 
al., 2005). All of these major cytokines (including IL10) 
are targets of miR-16a in our bioinformatics analysis 
(Table 2).
From the available evidence it can be speculated that 
lower expression of miR-16a due to IMI might have al-
lowed for greater mRNA expression of IL8 (infected vs. 
healthy fold change = 1,054), IL6 (fold change = 430), 
and IL10 (fold change = ~28) before peak clinical signs 
of mastitis (Moyes et al., 2009a). Interleukin-8 is an im-
portant component of the innate immune response and 
is involved in chemotaxis of polymorphonuclear leuko-
cytes. A greater expression of IL8 in mammary epithe-
lial cells in response to E. coli infection was observed 
previously (Günther et al., 2009). Interleukin-10 is an 
antiinflammatory cytokine and suppresses the produc-
tion of other inflammatory cytokines such as TNF, IL1, 
and IL6 by blocking nuclear factor κβ (NFκβ). Thus, it 
seems logical that a lower expression of miR-16a (and 
also miR-15b) would occur before peak clinical signs of 
mastitis.
Our data suggested that miR-16a in bovine mam-
mary tissue might control the level of key inflammatory 
components. As such, it would play both a direct and 
indirect role in regulating the appropriate response to 
an IMI. Despite this seemingly important role during 
mastitis infection, the marked upregulation of these 
proinflammatory signals and TLR2 (Moyes et al., 
2009a) also suggest that potential counterregulatory 
mechanisms to control overt inflammation might have 
been curtailed (i.e., upregulation of miR-146a is key in 
the control of inflammation; Nahid et al., 2011) but was 
not affected by IMI (Table 1). We speculate that the 
high dose of Strep. uberis used might have overwhelmed 
the molecular systems controlling inflammation.
Table 1. Expression of microRNA (miRNA; log-transformed data) 
in healthy or Streptococcus uberis-infected mammary tissue from 




miR-10a −0.77 −0.28 0.23 0.16
miR-15b −1.52 −0.45 0.44 0.09
miR-16a −0.60 −0.27 0.07 0.01
miR-17 −1.43 −0.80 0.80 0.56
miR-21 −1.01 −0.65 0.53 0.64
miR-31 −0.78 −0.17 0.22 0.07
miR-145 −1.02 −0.29 0.28 0.09
miR-146a −0.76 −0.40 0.53 0.64
miR-146b −0.51 −0.25 0.17 0.31
miR-155 −1.31 −0.79 0.58 0.53
miR-181a −5.87 −2.24 1.30 0.05
miR-205 −2.07 −2.02 0.36 0.94
miR-221 −2.72 −2.32 0.36 0.45
miR-223 −0.64 −1.54 0.12 0.01
Table 2. Subset of target genes (P ≤ 0.01) of microRNA (miRNA) among previously identified differentially expressed genes (DEG; Moyes et 
al., 2009a)1 
miRNA Upregulated Downregulated
miR-10a ARG2, STAT3, ACTG1, PSTPIP2, NR4A3, TNFAIP2, SRGN, 
CCR1
SLC30A4, AAK1
miR-15b/16a SLC30A4, FASN, BTN1A1, UBE2Q1, ADRB2, FOS, IL6, IL10, 
IL10RB, IL18, LYZ, TNF, IL8
FGF7, NOB1, IL10RA, ACSL5, TFPI2, HSPA8, 
ARRDC4, PPAP2B, CD69, BTG2, SLC2A3
miR-17 MEF2C, SSH2, FGL2, STAT3, LTV1, MAP3K8, CX3CL1, FGF, 
MPZL2, HSPA8, THBS1, CASP4, NR4A3, MXD1, CXCL6, 
CD69, IL8, SOD2, LDLR
LPIN1, IGF2BP2, BTN1A1, ZBTB38, MGEA5, 
GPAM, AAK1, C5orf13, CLSTN1
miR-21 FGL2, STAT3, LTV1, OLR1, FGF7, CCL20, THBS1, CD69, 
BTG2, CTSC, TNF
ZBTB38
miR-31 ITGAV, FGF7, CALR, TMEM49, CD55, CTSC, HIF1A, 
TWISTNB
LPIN1, BTN1A1
miR-145 SSH2, DLC1, NOLC1, PRKX, CXCR2, MPZL2, ACTG1, 
VCAM1, DNAJB11, ZFP36, NR4A3, TNFAIP2, FSCN1
FAM55C
miR-146a/b SOCS3, CKAP4, ARID3A, ERRFI1, SDCBP, BTG2, IL8, CTSC, 
SLC2A3, IL10, IL10RB, LDLR, TNF
DNAJC12, C5orf13, TNFAI P8, DLC1
miR-155 SSH2, FGL2, FGF7, F13A1, ACSL5, PHC2, SPI1, FO, SDCBP, 
C14orf147, IL6, BIRC3, FOS, IL18, LTF, TNF
CD36, FZD5, ZBTB38, C12orf65, AAK1, 
TNFAIP8
miR-181a TLR4, FOS, LIF, PLAU, SOCS3, BHLHE40, LTV1, MAP3K8, 
VCAM1, CXCL2, CALR, MARCKS, ARRDC4, PPAP2B, 
HSPA5, NR4A3, FOS, CD69, C15orf48, SRGN, SLC2A3, IL18, 
INSIG1, LTF
IGF2BP2, SCD, GPAM, AAK1
miR-221 SOD2, C14orf147, SDCBP, FOS, ZFP36, PPAP2B, THBS1, 
ARRDC4, MARCKS, HSPA8, SOCS3
TPD52L1, AAK1, GPAM, IGF2BP2
miR-223 MEF2C, IL6, LYZ, TNF TRAF3IP3, C12orf65, CLSTN1, LPL, IGF1R
miR-205 PEG3, ZBTB38, GPAM, AAK1, CD24, TNFAIP8 DLC1, IL15RA, PHC2, MARCKS, ERRFI1
1A full list of target genes is reported in the Supplementary Material (available online at http://www.journalofdairyscience.org/).
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miR-223
The miR-223 was the only upregulated miRNA in re-
sponse to IMI (Table 1). This miRNA has been studied 
primarily in granulocytes and neutrophils (Johnnidis 
et al., 2008) and bovine blood monocytes (Dilda et al., 
2012). A previous study observed no changes in miR-
223 expression in bovine blood monocytes challenged 
for 14 h with a small dose (100 ng) of Strep. aureus en-
terotoxin B and E. coli (Dilda et al., 2012). In addition 
to its upregulation, target genes of miR-223 exhibited 
different behavior in the bioinformatics analysis relative 
to responses found with other miRNA targets. Using 
the DIA with KEGG (Figure 1; Supplementary Tables, 
available online at http://www.journalofdairyscience.
org/) revealed an overall inhibition of “organismal sys-
tems” (Supplementary Table 10) including inhibition of 
“immune system” (several signaling pathways), “endo-
crine system” (e.g., insulin signaling), “excretory sys-
tem,” and “nervous system.” Within “human diseases” 
(Supplementary Table 11), analysis revealed that an 
overall inhibition of “infectious” (e.g., bacterial invasion 
of epithelial cells) and “metabolic” diseases. Within 
“metabolism” (Supplementary Table 6), “lipid metabo-
lism” (e.g., sphingolipid metabolism) and “metabolism 
of cofactors and vitamins” (nicotinamide metabolism) 
were inhibited and “nucleotide metabolism” (purine 
metabolism) and “folate metabolism” were activated 
(Figure 1; Supplementary Table 6, available online at 
http://www.journalofdairyscience.org/). Within “cellu-
lar processes” (Supplementary Table 9) only “transport 
and catabolism” of lysosome was activated by miR-223, 
whereas “endocytosis” and “peroxisome” were the most 
impacted and inhibited.
Previously reported roles of miR-223 include nega-
tive regulation of neutrophil proliferation, granulocyte 
differentiation, and inhibition of cell cycle progression 
via downregulation of elongation factor E2F (Fazi 
et al., 2005; Johnnidis et al., 2008). Expression of 
miR-223 is partly controlled by C/EBPα (CCAAT 
enhancer-binding factor) and NF1-A (a transcription 
factor of the CCAAT family; Fazi et al., 2005). In hu-
man granulocytes, C/EBPα activates the transcription 
of miR-223 and NF1-A inhibits its transcription by 
binding to the promoter (Fazi et al., 2005). The ef-
fects of C/EBPα on inhibition of cellular proliferation 
are mediated by directly inhibiting cyclin-dependent 
kinases (CDK2 and CDK4) or by inducing miR-223 
expression to block E2F2 (Fazi et al., 2005). In ad-
dition, in cultured macrophages, C/EPB was shown 
to be a direct target of miR-155 (Worm et al., 2009). 
Although miR-155 was not differentially expressed in 
our study, the upregulation of isoforms of C/EPB [C/
EBPD (1.97-fold change, infected vs. control) and C/
EBPB (1.27-fold change; Moyes et al., 2009a)] might 
have been partly responsible for the greater expression 
of miR-223 in mammary tissue. In addition, miR-223 
also enhances its own expression indirectly by inhibit-
ing the expression NF1A (Fazi et al., 2005). The inhibi-
tion of various signaling pathways containing targets of 
miR-223 (Figure 2), suggesting that CEBP might play 
an important regulatory role in mammary adaptations 
to infection via miR-223.
Of all signaling pathways associated with targets 
of miR-223 within “environmental information and 
processing” (Supplementary Table 8, available online 
at http://www.journalofdairyscience.org/), Notch 
and mitogen-activated protein kinase (MAPK) were 
highly affected and activated with IMI (Figure 2). 
In contrast, ECM-receptor interaction, vascular en-
dothelial growth factor (VEGF) signaling, epidermal 
growth factor receptor (ErbB) signaling, transforming 
growth factor β (TGF-β) signaling, and cell adhesion 
molecules (CAM) were highly impacted but inhib-
ited (Figure 2). Although cytokine-cytokine receptor 
interaction was highly impacted, the overall flux was 
only modestly activated. Within “organismal system” 
(Supplementary Table 10, available online at http://
www.journalofdairyscience.org/), RIG-I-like receptor 
signaling was the most impacted and inhibited (Figure 
2). Only NOD-like receptor signaling was activated by 
alterations in miR-223 targets but the overall impact 
was low compared with RIG-I-like receptor signaling. 
These results revealed that among all tested miRNA, 
only miR-223 altered Notch signaling (i.e., this pathway 
might be specifically regulated by target genes with 
altered expression in response to Strep. uberis).
Notch signaling plays a critical role in steering an im-
mune response toward inflammation by regulating the 
expression of various proinflammatory cytokines, which 
in turn, activate the pathway further (Benson et al., 
2004). From that standpoint, the discovery that miR-
223 upregulation during IMI led to an activation of 
“leukemia inhibitory factor receptor binding” and “inter-
leukin-12 receptor binding” (Supplementary Table 12, 
available online at http://www.journalofdairyscience.
org/) appears to confirm previous observations from 
the murine mammary gland, which underscored that 
the mammary tissue is immune responsive (Clarkson 
et al., 2004; Piantoni et al., 2010). The gene ontology 
(GO) analysis using the DIA (Supplementary Table 
12) further highlighted a potential key role of miR-
223 in bovine mammary epithelial cells (i.e., “inhibin 
binding,” “insulin binding,” “activin receptor activity,” 
“folic acid binding,” and “thyroxine 5c-deiodinase ac-
tivity” were markedly inhibited. Several of those bio-
logical processes have been previously shown to play 
important roles in bovine mammary tissue metabolism 
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and development (Phillips, 2005; Capuco et al., 2008; 
Menzies et al., 2009).
From a mechanistic standpoint, the inhibition of 
several cellular signaling pathways (e.g., TGF-β, ECM-
receptor interaction, ErbB, and phosphatidylinositol; 
Figure 2) by upregulation of miR-223 might have been 
mediated in part via downregulation of IGF1R (Figure 
1), which is required for IGF-1 signaling and enhances 
bactericidal activity of neutrophils (Inoue et al., 1998). 
Although we did not measure serum IGF-1 in these 
Figure 2. Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/) pathway results for the most-impacted cat-
egories within “organismal systems,” “environmental information processing,” and “genetic information processing” uncovered by the dynamic 
impact approach (DIA) analysis using differentially expressed genes (DEG) that are putative targets of miR-31, -145, -181a, -223, and -15b/16a. 
Shown are the overall impact (left column) and flux (right shaded column) of the pathways for microRNA (miRNA; P < 0.10). For interpreta-
tion of flux, gray horizontal bars (increasing toward the left) denote inhibition and black horizontal bars (increasing toward the right) denote 
activation. The length of the bar in the left column denotes the extent of the impact. Color version available in the online PDF.
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cows, the increase in serum insulin concentration post-
IMI challenge (Moyes et al., 2009b) and the inhibition 
of “insulin binding” (Supplementary Table 12, available 
online at http://www.journalofdairyscience.org/) could 
be taken as an indication of reduced mammary sensi-
tivity to anabolic hormones including IGF-1. Overall, 
the inhibition of “insulin binding” and IGF1R agreed 
with our previous analysis using IPA demonstrating an 
inhibition of IGF-1 signaling with IMI (Moyes et al., 
2009a); however, an additional regulatory role of miR-
NA was revealed by the current integrative approach 
(i.e., components of this pathways such as protein ki-
nase C, IGF2BP2, and IGFBP5 are targets of several 
miRNA: miR-17, miR-221, and miR-223).
Insulin-like growth factor 1 signaling is not only in-
volved in synthesis of milk protein but also plays a 
crucial role in maintaining the integrity of mammary 
epithelial tissue (Bionaz and Loor, 2011), thus under-
scoring its importance during lactation. In addition, by 
delaying the apoptotic response of resident neutrophils 
(Himpe et al., 2008) IGF-1 signaling mediated through 
the PI3K/AKT pathway (Popova et al., 2009) confers 
resistance (i.e., increased survival during infection) to 
mammary epithelial cells against infection. The inhi-
bition of the pathway (Moyes et al., 2009a) strongly 
suggests a weakening of epithelial cells after infection. 
A compromised integrity of epithelial cells followed by 
shedding might be associated with the inhibition of the 
aforementioned pathways. If that holds true in mam-
mary tissue after IMI, our data suggest that apoptosis 
of neutrophils was probably substantial at 20 h after 
inoculation (Moyes et al., 2010).
A potentially negative modulation of the mammary 
tissue immune response (i.e., dysregulation) by miR-
223 upregulation was underscored in the current study 
by the observed inhibition of “FcγR-mediated phagocy-
tosis,” “leukocyte transendothelial migration,” “natural 
killer cell mediated cytotoxicity,” “T cell receptor sig-
naling,” and “RIG-I like receptor signaling.” An inhibi-
tion of the latter, in particular, might have negative 
consequences in terms of the mammary cell’s ability to 
produce antiviral cytokines (Bruns and Horvath, 2012) 
that may be functional during IMI. From a biological 
standpoint, a negative modulation of immune response 
might be required during inflammation in mammary 
cells to avoid damage to host tissue (Lindsay, 2008). 
The lack of change in miR-146a coupled with the 
marked upregulation of TLR2 (Moyes et al., 2009a) 
underscored the existence of dysregulation during IMI 
because miR-146a is a key controller of the inflamma-
tory response (Nahid et al., 2011). A deeper analysis 
of the biological functions and effects of the expression 
of miR-223 in mammary epithelial cells is needed to 
clarify the exact link between our observations and the 
disease.
miR-181a
A lower expression of miR-181a (P < 0.05) in re-
sponse to IMI was observed in this study. A list of 
miR-181a target genes affected by IMI is shown in the 
Supplementary Material (available online at http://
www.journalofdairyscience.org/). The lower miR-181a 
expression was associated with activation of FcγR-
mediated phagocytosis, toll-like receptor (TLR) signal-
ing, B cell receptor signaling, antigen processing and 
presentation, protein export, protein processing in the 
endoplasmic reticulum (ER), and ubiquitin-mediated 
proteolysis (Figure 2; Supplementary Tables 10 and 11, 
available online at http://www.journalofdairyscience.
org/). All of these have clear roles in the immune 
system response to IMI. Among signaling pathways 
unrelated to immune system per se, we observed that 
TGF-β, Janus kinase-signal transducer and activator of 
transcription (JAK-STAT), MAPK, Wnt, and ABC 
transporter signaling were highly affected and activated 
(Figure 2). Additional GO analysis using the DIA re-
vealed non-immune-related functions affected by genes 
under partial control of miR-181a (e.g., “lipid phos-
phatase activity,” “glucose transmembrane transport,” 
“tRNA methyltransferase activity,” and “stearoyl-CoA 
desaturase activity”; Supplementary Table 12, avail-
able online at http://www.journalofdairyscience.org/). 
Interestingly, just as was the case with miR-223, highly 
affected GO functions included “leukemia inhibitory 
factor activity” and “inhibin binding.”
Toll-like receptor signaling is a major player of im-
mune activation after infection, and leads to synthesis 
of proinflammatory cytokines (e.g., TNF, IL1B, and 
IL6). Lipopolysaccharide from gram-negative bacteria 
stimulates the TLR4 signaling pathway and is a key 
mediator of innate immunity. Prior work has revealed 
the upregulation of TLR4, FOS, IL8, and IL6 in mam-
mary tissue after IMI challenge with gram-positive 
bacteria (Lutzow et al., 2008). The TLR pathway was 
induced in our analysis by all differentially expressed 
miRNA but the strongest activation was observed for 
miR-181a (Figure 2; Supplementary Table 10, available 
online at http://www.journalofdairyscience.org/). A 
stronger activation with miR-181a also was observed 
for protein export and protein processing in the ER 
(“genetic information processing”), both of which might 
be related to the proinflammatory cytokine response. 
Among several genes of the TLR pathway upregulated 
during IMI challenge (Moyes et al., 2009a), the IPA 
analysis revealed 2 targets of miR181a (i.e., TLR4 
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and FOS; Table 2), which had greater expression after 
IMI and support the involvement of inflammation and 
apoptosis during the process of tissue remodeling as a 
result of inflammation (Clarkson et al., 2004).
Our results suggest that miR-181a could regulate 
proinflammatory genes within the TLR signaling path-
way during mastitis. It also is possible that TLR sig-
naling during infection of the mammary gland induces 
other miRNA that exert control on the expression of 
genes composing the pathway (e.g., TLR4 activation 
was more effective than TLR2 or TLR3 in upregulat-
ing miR-147 expression, which subsequently led to 
upregulation of TNF; Liu et al., 2009). Although not 
affected in our study, miR-146a is key for controlling 
TLR2 and TLR4 signaling (i.e., it operates as negative 
feedback mechanism to prevent uncontrolled inflam-
mation; Nahid et al., 2011). Thus, the fact that both 
TLR2 and TLR4 were upregulated due to IMI (Moyes 
et al., 2009a) underscores a potentially important role 
of miRNA networks in controlling local inflammation. 
Our data on TLR2 and miR-146a would suggest that 
the miRNA control mechanisms might have been im-
paired by the dose of Strep. uberis.
A role in T-cell differentiation (Chen et al., 2004) 
and T-cell receptor (TCR) signaling sensitivity (Li et 
al., 2007) has been demonstrated for miR-181a. The 
TCR signaling and antigen processing and presentation 
pathways involve phosphorylation and dephosphoryla-
tion events. The miR-181a increases T cell strength and 
sensitivity by downregulating the mRNA and protein 
expression of non-receptor-type tyrosine phosphatases 
(PTPN) or dual-specificity phosphatases [DUSP; ex-
tracellular regulated kinase (ERK) dephosphorylation] 
that negatively regulate TCR signaling (Li et al., 
2007). The bioinformatics analysis supports a role for 
miR-181a in the control of phosphatase and transport 
activity (Supplementary Table 12, available online at 
http://www.journalofdairyscience.org/) in mammary 
tissue. In the former, downregulation with IMI might 
have enhanced sensitivity to specific signaling cues, 
whereas the enhanced transport activity might have 
been related in part with glucose use by immune and 
mammary epithelial cells.
The activation of the JAK-STAT signaling pathway 
by miR-181a also was a unique feature, as it had a large 
impact relative to other miRNA (Figure 2). Leukemia 
inhibitory factor (LIF) activates the JAK-STAT and 
MAPK pathways in nonruminant cells (Kunisada et 
al., 1996). The former is known to regulate the phos-
phatidylinositol pathway in the mouse mammary gland 
(Abell and Watson, 2005), partly by controlling inflam-
mation via activation of NFκβ (Ozes et al., 1999; i.e., 
LIF mRNA is upregulated in various inflammatory 
conditions; Szepietowski et al., 2004). From a mecha-
nistic standpoint the high impact and degree of activa-
tion of LIF receptor binding (Supplementary Table 12, 
available online at http://www.journalofdairyscience.
org/) by miR-223 and miR-181a is a remarkable fea-
ture because of the divergent response of these miRNA 
to IMI (i.e., one was upregulated, whereas the other 
one was downregulated). However, this probably is not 
surprising, given the overlap in target genes by several 
miRNA (Supplementary Table 4). In murine mammary 
epithelial cells the induction of LIF expression is neces-
sary for cellular apoptosis (Schere-Levy et al., 2003) 
and might have contributed (Zhao and Lacasse, 2008) 
to increasing that process during IMI in our study. The 
regulation of a wide range of phosphatases (Li et al., 
2007) and the T cell sensitivity (Chen et al., 2004) to 
antigens underscores the role of miRNA in regulating 
proinflammatory responses in mammary epithelial cells.
miR-31
In our study, miR-31 was downregulated (P = 0.07) 
in response to infection (Table 1). The high impact 
and marked induction of “cancer” revealed by KEGG 
analysis (Figure 1) underscored an association of miR-
31 with cellular survival and death pathways (Wnt 
and MAPK signaling), including vascularization (e.g., 
VEGF signaling; Figure 2). Interestingly, mammalian 
target of rapamycin (mTOR) signaling also was highly 
affected but was the only one inhibited by differential 
expression of miR-31 targets. Additional pathways that 
were highly affected and activated by miR-31 target 
genes were soluble NSF attachment protein receptor 
(SNARE) complex and protein processing in the ER. 
Recent studies with dairy cows (Bionaz and Loor, 2011) 
and mice (Chat et al., 2011) have revealed important 
functions for mTOR signaling and SNARE proteins 
during lactation, underscoring the potential importance 
of our findings in the context of mastitis infection. In 
neutrophils, the SNARE protein complexes are essen-
tial for extracellular release of cytoplasmic granules as 
a means to combat infectious pathogens during infec-
tion (Mollinedo et al., 2006). Thus, the activation of 
vesicular transport via SNARE proteins might have 
served as a defense mechanism to destroy Strep. uberis. 
A detailed analysis of angiogenesis with respect to in-
flammation has been discussed in our previous report 
dealing with the mammary transcriptome (Moyes et 
al., 2009a).
Previous work with different mastitis pathogens 
revealed that IL1B plays a central role in promoting 
mammary cell apoptosis during IMI (Zhao and Lac-
asse, 2008). The high impact and activation of “inter-
leukin-1 binding” and “interleukin-1 receptor activity” 
(Supplementary Table 12, available online athttp://
6406 NAEEM ET AL.
Journal of Dairy Science Vol. 95 No. 11, 2012
www.journalofdairyscience.org/) among target genes 
regulated by miR-31 coupled with the ~40-fold upregu-
lation of IL1R2 (Moyes et al., 2009a) seems to support 
a role for this miRNA in controlling the balance be-
tween mammary cell apoptosis or proliferation during 
infection. In mammary cancer cell lines with a defective 
p53 signaling pathway, the overexpression of miR-31 
inhibited proliferation and induced apoptosis; however, 
in wild-type cells, miR-31 had no effect (Creighton et 
al., 2010). In other studies, blocking miR-31 expression 
reduced growth of tumor xenografts (Liu et al., 2010). 
Our data suggest that miR-31 could play a similar role 
in bovine mammary epithelial cells (i.e., apoptotic path-
ways per se were not among the most affected, whereas 
several associated with cell survival and angiogenesis 
were activated; Figure 2). However, the inhibition of 
mTOR signaling and phosphatidylinositol (miR-181a) 
also suggests a link between miR-31 and apoptosis 
because these pathways are commonly disrupted in 
breast cancer (Hernandez-Aya and Gonzalez-Angulo, 
2011). We recently demonstrated that both mTOR 
and JAK-STAT pathways in bovine mammary tissue 
are upregulated during established lactation and likely 
help coordinate mammary protein synthesis and the 
control of proliferation versus apoptosis (Bionaz and 
Loor, 2011).
CONCLUSIONS
Bioinformatics analysis of miRNA and target gene 
expression provided a more holistic view of the under-
lying mechanisms affected by IMI with Strep. uberis. 
Differential expression of miR-16a, -31, -181a, and -223 
provided evidence for the involvement of miRNA in 
controlling not only immune response but also cellular 
signaling, survival, and metabolism. Most of the dif-
ferentially expressed miRNA were downregulated with 
IMI; however, because several target genes are regu-
lated by more than 1 miRNA, it appears likely that a 
coordinated network of control exists among miRNA. 
The KEGG analysis suggested an inhibitory effect of 
most miRNA on metabolic pathways but an induction 
of the immune response. Because the inflammatory 
response to infection must be robust enough to destroy 
invading pathogens but also be resolved in a timely 
manner to avoid excessive damage to host cells, it is 
not surprising that the miRNA in this study appeared 
to be involved in both aspects of inflammation. The 
relevance of altered miRNA expression to immune re-
sponse in mammary cells remains to be elucidated. We 
identified several potential miRNA-mRNA associations 
underlying several biological pathways related to the 
immune response. Our study does not exclude the pos-
sibility that these miRNA may directly or indirectly 
influence mammary tissue tolerance to infection. Over-
all, compelling evidence now exists for the regulation 
of immune activation, immune cell differentiation, and 
regulation of immune response and metabolism by 
miRNA. Thus, the identification of miRNA and their 
respective targets may offer new therapeutic strategies 
to treat immunological and infectious diseases such as 
mastitis.
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